Browsing publications by Professor Farhad Kamali

Newcastle AuthorsTitleYear
Dr Patrick Kesteven
Professor Ann Daly
Dr Peter Avery
Professor Farhad Kamali
A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study2013
Dr Patrick Kesteven
Julian Leathart
Professor Ann Daly
Professor Farhad Kamali
A Randomized Trial of Genotype-Guided Dosing of Warfarin2013
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Dr John Hanley
Dr Jing Shen
et al.
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K2013
Dr Tina Biss
Dr Peter Avery
Professor Farhad Kamali
The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children2013
Professor Ann Daly
Professor Farhad Kamali
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs2012
Professor Farhad Kamali
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users2012
Professor Farhad Kamali
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data2012
Dr Ellen Hatch
Dr Iain Matthews
Professor Ann Daly
Professor Farhad Kamali
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors2012
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Professor Farhad Kamali
VKORC1 and CYP2C9 genotype is associated with over-anticoagulation during initiation of warfarin therapy in children2012
Dr Tina Biss
Professor Farhad Kamali
Warfarin anticoagulation in children: is there a role for a personalized approach to dosing?2012
12345678910